Cargando…

Myeloprotective Activity of Deoxyspergualin: Influence on Splenic Colony‐forming Cell Injury and Antitumor Activity of Mitomycin C in Mice

We have examined the efficacy of deoxyspergualin (DSG) in protecting splenic colony‐forming cells (CFU‐S) from mitomycin C (MMC)‐induced damage. The main findings of the study are as follows. (1) When DSG was administered at doses of 1.5 and 3 mg/kg for 7 days before the MMC injection, the decrease...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nemoto, Kyuichi, Sugawara, Yumi, Ogino, Miwa, Mae, Takako, Abe, Fuminori, Takeuchi, Tomio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1992
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918928/ https://www.ncbi.nlm.nih.gov/pubmed/1517153 http://dx.doi.org/10.1111/j.1349-7006.1992.tb01981.x

Ejemplares similares

Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study
por: Lorenz, Hanns-Martin, et al.
Publicado: (2011)

Cytostatic Effect of Deoxyspergualin on a Murine Leukemia Cell Line L1210
por: Hiratsuka, Masaharu, et al.
Publicado: (1991)

Myeloprotection with activated carbon in doxorubicin-treated rats
por: Gerashchenko, Bogdan I., et al.
Publicado: (2023)

The immunosuppressant 15-deoxyspergualin [correction of 1,5- deoxyspergualin] reveals commonality between preT and preB cell differentiation
Publicado: (1996)

Efficacy of deoxyspergualine for antibody-mediated rejection and proteinuria after kidney transplantation
por: Ishida, Hideki, et al.
Publicado: (2008)

Improving Outcomes of Chemotherapy: Established and Novel Options for Myeloprotection in the COVID-19 Era
por: Lyman, Gary H., et al.
Publicado: (2021)

Myeloprotective activity of crude methanolic leaf extract of Cassia occidentalis in cyclophosphamide-induced bone marrow suppression in Wistar rats
por: Neboh, Emeka E, et al.
Publicado: (2015)

Antiemetic and Myeloprotective Effects of Rhus verniciflua Stoke in a Cisplatin-Induced Rat Model
por: Kim, Hyo-Seon, et al.
Publicado: (2017)

Myeloperoxidase Enhances Etoposide and Mitoxantrone-Mediated DNA Damage: A Target for Myeloprotection in Cancer Chemotherapy
por: Atwal, Mandeep, et al.
Publicado: (2017)

Variations in exposure to mitomycin C in an in vitro colony-forming assay.
por: Slee, P. H., et al.
Publicado: (1986)

Double-blind randomized study on the myeloprotective effect of melatonin in combination with carboplatin and etoposide in advanced lung cancer
por: Ghielmini, M, et al.
Publicado: (1999)

Design and synthesis of coumarin-based organoselenium as a new hit for myeloprotection and synergistic therapeutic efficacy in adjuvant therapy
por: Patra, Arup Ranjan, et al.
Publicado: (2018)

Antitumor Activity of a Novel Double-Targeted System for Folate Receptor-Mediated Delivery of Mitomycin C
por: Xu, Yan, et al.
Publicado: (2020)

Exploratory composite endpoint demonstrates benefit of trilaciclib across multiple clinically meaningful components of myeloprotection in patients with small cell lung cancer
por: Dómine Gómez, Manuel, et al.
Publicado: (2021)

Tumor Localization and in vivo Antitumor Activity of the Immunoconjugate Composed of Anti‐human Colon Cancer Monoclonal Antibody and Mitomycin C‐Dextran Conjugate
por: Noguchi, Akinori, et al.
Publicado: (1991)

Mitomycin C and decarbamoyl mitomycin C induce p53-independent p21(WAF1/CIP1) activation
por: Cheng, Shu-Yuan, et al.
Publicado: (2016)

Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factor.
por: Kornek, G. V., et al.
Publicado: (1996)

Phase I study of mitozantrone, methotrexate and mitomycin with granulocyte colony-stimulating factor (filgrastim) in patients with advanced breast cancer.
por: O'Brien, M. E., et al.
Publicado: (1994)

Effect of mitomycin C on the secretion of granulocyte macrophages colonies stimulating factor and interleukin-5 in eosinophilic nasal polyps stromal culture
por: Crosara, Paulo Fernando Tormin Borges, et al.
Publicado: (2015)

Enhanced Antitumoral Activity and Photoacoustic Imaging Properties of AuNP‐Enriched Endothelial Colony Forming Cells on Melanoma
por: Armanetti, Paolo, et al.
Publicado: (2020)

Transconjunctival penetration of mitomycin C
por: Velpandian, T, et al.
Publicado: (2008)

Enhanced ATPase Activity in Liver Cell Nuclei Induced by Administration of Mitomycin C to Rats
por: Wakizaka, Akira, et al.
Publicado: (1989)

Effect of photodynamic therapy in combination with mitomycin C on a mitomycin-resistant bladder cancer cell line.
por: Datta, S. N., et al.
Publicado: (1997)

A unique cytosolic activity related but distinct from NQO1 catalyses metabolic activation of mitomycin C
por: Joseph, P, et al.
Publicado: (2000)

Cisplatin‐incorporated Polymeric Micelles Eliminate Nephrotoxicity, While Maintaining Antitumor Activity
por: Mizumura, Yasuo, et al.
Publicado: (2001)

Mitomycin C. Current Status and Developments
por: Fox, B. W.
Publicado: (1980)

EFFECTS OF MITOMYCIN C ON HUMAN CHROMOSOMES
por: Cohen, Maimon M., et al.
Publicado: (1964)

Mitomycins syntheses: a recent update
por: Andrez, Jean-Christophe
Publicado: (2009)

Jungle Honey Enhances Immune Function and Antitumor Activity
por: Fukuda, Miki, et al.
Publicado: (2011)

Effectiveness of an Immediate Mitomycin C Instillation in Patients with Superficial Bladder Cancer Receiving Periodic Mitomycin C Instillation
por: Jung, Seok Jin, et al.
Publicado: (2011)

Outcomes of Trabeculectomy With and Without Mitomycin C in Pseudoexfoliative Glaucoma Compared With Mitomycin C in Primary Open Angle Glaucoma
por: LOPES, Ana Sofia, et al.
Publicado: (2019)

Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers – a new active regimen
por: Slater, S, et al.
Publicado: (2002)

Myeloprotective Effects of Trilaciclib Among Patients with Small Cell Lung Cancer at Increased Risk of Chemotherapy-Induced Myelosuppression: Pooled Results from Three Phase 2, Randomized, Double-Blind, Placebo-Controlled Studies
por: Hussein, Maen, et al.
Publicado: (2021)

Comparison of Surgical Outcomes between Trabeculectomy with Mitomycin C and Ahmed Valve Implantation with Mitomycin C in Eyes with Uveitic Glaucoma
por: Lee, Seung Yeop, et al.
Publicado: (2022)

Association Between Phase Coupling of Respiratory Sinus Arrhythmia and Slow Wave Brain Activity During Sleep
por: Niizeki, Kyuichi, et al.
Publicado: (2018)

Anticellular and Antitumor Activity of Duocarmycins, Novel Antitumor Antibiotics
por: Gomi, Katsushige, et al.
Publicado: (1992)

Inhibition of Colony Formation of Drug‐resistant Human Tumor Cell Lines by Combinations of Interleukin‐2‐activated Killer Cells and Antitumor Drugs
por: Ohtsu, Atsushi, et al.
Publicado: (1989)

The hTERT Promoter Enhances the Antitumor Activity of an Oncolytic Adenovirus under a Hypoxic Microenvironment
por: Hashimoto, Yuuri, et al.
Publicado: (2012)

Postoperative Bleb Management with Topical Mitomycin-C
por: Jonas, Jost B
Publicado: (2011)

Differential Toxicity of DNA Adducts of Mitomycin C
por: Bargonetti, Jill, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_omr4hnigju7kfgfsjhuuc32e6b